BCR-ABL-independent and RAS / MAPK pathway-dependent form of imatinib resistance in Ph-positive acute lymphoblastic leukemia cell line with activation of EphB4.
Eur J Haematol
; 84(3): 229-38, 2010 Mar.
Article
in En
| MEDLINE
| ID: mdl-20002159
Full text:
1
Database:
MEDLINE
Main subject:
Piperazines
/
Pyrimidines
/
Fusion Proteins, bcr-abl
/
Ras Proteins
/
Drug Resistance, Neoplasm
/
Receptor, EphB4
/
Protein Kinase Inhibitors
/
Precursor Cell Lymphoblastic Leukemia-Lymphoma
/
Neoplasm Proteins
Limits:
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Eur J Haematol
Journal subject:
HEMATOLOGIA
Year:
2010
Type:
Article
Affiliation country:
Japan